Tullius, Stefan Günther: Die chronische Transplantatschädigung -Mechanismen, Risikofaktoren, Therapie-

46

Literatur

1. Tilney NL, Whitley WD, Diamond JR, Kupiec WJ, Adams DH: "Chronic rejection-an undefined conundrum. " Transplantation 1991, 52, S389, 0041-1337.

2. Hayry P, Mennander A, Yilmaz S, et al: "Towards understanding the pathophysiology of chronic rejection. " Clin.Investig. 1992, 70, S780, 0941-0198.

3. Paul LC, Fellstrom B: "Chronic vascular rejection of the heart and the kidney-have rational treatment options emerged? " Transplantation 1992, 53, S1169, 0041-1337.

4. Tullius SG, Tilney NL: "Both alloantigen-dependent and -independent factors influence chronic allograft rejection. " Transplantation 1995, 59, S313, 0041-1337.

5. Paul LC, Hayry P, Foegh M, et al: "Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. " Transplant Proc. 1993, 25, S2022, 0041-1345.

6. Hume DM, Merrill JP, Miller BF, Thorn GW: "Experience with renal homotransplantation in the human: Report of nine cases. " J.Clin.Invest. 1955, 34, S326, 0021-9738.

7. Porter KA, Thomson WB, Owen K, Kenyon JR, Mowbray JF: "Obliterative changes in four kidney homotransplants. " Br.J.Med.. 1963, 2, S639,

8. Kincaid SP: "Histological diagnosis of rejection of renal homografts in man. " Lancet 1967, 2, S849, 0140-6736.

9. Lindquist RR, Guttmann RD, Merrill JP, Dammin GJ: "Human renal allografts. Interpretation of morphologic and immunohistochemical observations. " Am.J.Pathol. 1968, 53, S851, 0002-9440.

10. Busch GJ, Galvanek EG, Reynolds ES Jr: "Human renal allografts. Analysis of lesions in long-term survivors. " Hum.Pathol. 1971, 2, S253, 0046-8177.

11. Sibley RK, Payne W: "Morphologic findings in the renal allograft biopsy. " Semin.Nephrol. 1985, 5, S294, 0270-9295.

12. Thompson JG: "Atheroma in a transplanted heart. " Lancet 1969, 2, S1297, 0140-6736.

13. Bieber CP, Stinson EB, Shumway NE, Payne R, Kosek J: "Cardiac transplantation in man. VII. Cardiac allograft pathology. " Circulation 1970, 41, S753, 0009-7322.

14. Billingham ME: "Cardiac transplant atherosclerosis. " Transplant Proc. 1987, 19, S19, 0041-1345.

15. Uretsky BF, Murali S, Reddy PS, et al: "Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. " Circulation 1987, 76, S827, 0009-7322.

16. Starzl TE, Porter KA, Brettschneider L, et al: "Clinical and pathologic observations after orthotopic transplantation of the human liver. " Surg.Gynecol.Obstet. 1969, 128, S327, 0039-6087.


47

17. Demetris AJ, Lasky S, van Thiel DH, Starzl TE, Dekker A: "Pathology of hepatic transplantation. A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/ steroid regimen. " Am.J.Pathol. 1985, 118, S151, 0002-9440.

18. Demetris AJ, Markus BH, Burnham J, et al: "Antibody deposition in liver allografts with chronic rejection. " Transplant Proc. 1987, 19, S121, 0041-1345.

19. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD: "Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features. " Hrsg.: .: Hepatology 1991, 13, S882, 0270-9139.

20. Derom F, Barbier F, Ringoir S, et al: "Ten-month survival after lung homotransplantation in man. " J.Thorac.Cardiovasc.Surg. 1971, 61, S835, 0022-5223.

21. Yousem SA, Burke CM, Billingham ME: "Pathologic pulmonary alterations in long-term human heart-lung transplantation. " Hum.Pathol. 1985, 16, S911, 0046-8177.

22. Cecka JM: "The UNOS Scientific Renal Transplant Registry-ten years of kidney transplants. " Clin.Transpl. 1997, 1, 0890-9016.

23. Gjertson DW, Cecka JM, Terasaki PI: "The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. " Transplantation 1995, 60, S1384, 0041-1337.

24. Opelz G, Mickey MR, Terasaki PI: "Calculations on long-term graft and patient survival in human kidney transplantation. " Transplant Proc. 1977, 9, S27, 0041-1345.

25. Schweitzer EJ, Matas AJ, Gillingham KJ, et al: "Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s. " Ann.Surg. 1991, 214, S679, 0003-4932.

26. Mahony JF: "Long term results and complications of transplantation: the kidney. " Transplant Proc. 1989, 21, S1433, 0041-1345.

27. Gao SZ, Schroeder JS, Hunt S, Stinson EB: "Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. " Am.J.Cardiol. 1988, 62, S876, 0002-9149.

28. Gao SZ, Schroeder JS, Alderman EL, et al: "Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. " Circulation 1987, 76, SV56, 0009-7322.

29. Bechstein WO, Keck H, Müller AR, et al: "Inzidenz irreversibler ductopenischer Abstoßungen nach Lebertransplantationen. " Zeitschrift für Transplantationsmedizin 1993 (Suppl.), 17,

30. Wiesner RH, Ludwig J, van Hoek B, Krom RA: "Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. " Hepatology 1991, 14, S721, 0270-9139.

31. Stewart S: "Pathology of lung transplantation. " Semin.Diagn.Pathol. 1992, 9, S210, 0740-2570.

32. Sutherland D, Gruessner A, Moudry MK: "International Pancreas Transplant Registry report. " Transplant Proc. 1994, 26, S407, 0041-1345.


48

33. Nakhleh RE, Sutherland DE: "Pancreas rejection: Significance of histopathologic findings with implications for classification of rejection. " Am.J.Surg.Pathol. 1992, 16, S1098, 0147-5185.

34. Goulet O, Revillon Y, Jan D, et al: "Small-bowel transplantation in children. " Transplant Proc. 1990, 22, S2499, 0041-1345.

35. Langrehr JM, Banner B, Lee KK, Schraut WH: "Clinical course, morphology, and treatment of chronically rejecting small bowel allografts. " Transplantation 1993, 55, S242, 0041-1337.

36. Rose ML: "Antibody-mediated rejection following cardiac transplantation. " Transplantation Reviews 1993, 7, S140,

37. Russell PS, Chase CM, Winn HJ, Colvin RB: "Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. " J.Immunol. 1994, 152, S5135, 0022-1767.

38. Suciu-Foca N, Reed E, D'Agati VD, et al: "Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. " Transplantation 1991, 51, S593, 0041-1337.

39. Hancock WH, Whitley WD, Tullius SG, et al: "Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. " Transplantation 1993, 56, S643, 0041-1337.

40. Tilney NL: "Renal transplantation between identical twins: a review. " World J.Surg. 1986, 10, S381, 0364-2313.

41. Dammin GJ: "Renal transplants Correlations of histological patterns with function. " Hrsg.: Mostofi FK, Smith DE, eds: The Kidney, International Acadamy of Pathology, Monographie Nr.6 Baltimore, Williams and Wilkins, 1966 S445,

42. Glassock RJ, Feldman D, Reynolds ES, Dammin GJ, Merrill JP: "Human renal isografts: a clinical and pathologic analysis. " Medicine 1968, 47, S411, 0025-7974.

43. Kasiske BL: "Clinical correlates to chronic renal allograft rejection. " Kidney Int. Suppl. 1997, 63, S71, 0098-6577.

44. Rao KV, Kasiske BL, Odlund MD, Ney AL, Andersen RC: "Influence of cadaver donor age on posttransplant renal function and graft outcome. " Transplantation 1990, 49, S91, 0041-1337.

45. Wahlberg J, Tufveson G, Larsson A, Backman U, Frodin L: "Influence of the age of cadaveric kidney donors on transplantation outcome and rate of surgical complications. " Scand.J.Urol.Nephrol.Suppl. 1990, 131, S39, 0300-8886.

46. Alexander JW, Bennett LE, Breen TJ: "Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry. " Transplantation 1994, 57, S871, 0041-1337.

47. Isoniemi H, Nurminen M, Tikkanen MJ, et al: "Risk factors predicting chronic rejection of renal allografts. " Transplantation 1994, 57, S68, 0041-1337.


49

48. Weis M, von Scheidt W: "Cardiac allograft vasculopathy: a review. " Circulation 1997, 96, S2069, 0009-7322.

49. Chertow GM, Milford EL, Mackenzie HS, Brenner BM: "Antigen-independent determinants of cadaveric kidney transplant failure. " JAMA 1996, 276, S1732, 0098-7484.

50. Cecka JM, Terasaki PI: "The UNOS scientific renal transplant registry. United Network for Organ Sharing. " Clin.Transpl. 1995, 1, 0890-9016.

51. Nagano H, Tilney NL: "Chronic allograft failure: the clinical problem. " Am.J.Med.Sci. 1997, 313, S305, 0002-9629.

52. Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD: "Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. " Lancet 1999, 354, S1147, 0140-6736.

53. Chertow GM, Brenner BM, Mackenzie HS, Milford EL: "Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ Sharing. " Kidney Int.Suppl. 1995, 52, S48, 0098-6577.

54. Terasaki PI, Koyama H, Cecka JM, Gjertson DW: "The hyperfiltration hypothesis in human renal transplantation. " Transplantation 1994, 57, S1450, 0041-1337.

55. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM: "Renal transplantation in older people. " Lancet 1994, 343, S461, 0140-6736.

56. Brenner BM, Cohen RA, Milford EL: "In renal transplantation, one size may not fit all. " J.Am.Soc.Nephrol. 1992, 3, S162, 1046-6673.

57. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR: "Long-term follow-up after partial removal of a solitary kidney. " N.Engl.J.Med. 1991, 325, S1058, 0028-4793.

58. Najarian JS, Chavers BM, McHugh LE, Matas AJ: "20 years or more of follow-up of living kidney donors. " Lancet 1992, 340, S807, 0140-6736.

59. Frei U, Schindler R, Wieters D, Grouven U, Brunkhorst R, Koch KM: "Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction? " Nephrol.Dial.Transplant 1995, 10, S1206, 0931-0509.

60. Pratschke J, Wilhelm MJ, Kusaka M, et al: "Brain death and its influence on donor organ quality and outcome after transplantation. " Transplantation 1999, 67, S343, 0041-1337.

61. Cushing H: "Some experimental and clinical observations concerning states of increased intracranial tension. " Am.J.Med.Sci. 1902, 124, S373, 0002-9629.

62. Boyd GL, Phillips MG, Henry ML: "Cadaver donor management. In " Hrsg.: Philipps MG, ed: Organ procurement, preservation and distribution in transplantation Richmond, VA, 1996 S81,

63. Finkelstein I, Toledo PL, Castellanos J: "Physiologic and hormonal changes in experientally induced brain dead dogs. " Transplant.Proc. 1987, 19, S4156, 0041-1345.


50

64. Macoviak JA, McDougall IR, Bayer MF, Brown M, Tazelaar H, Stinson EB: "Significance of thyroid dysfunction in human cardiac allograft procurement. " Transplantation 1987, 43, S824, 0041-1337.

65. Mertes PM, el Abassi K, Jaboin Y, et al: "Changes in hemodynamic and metabolic parameters following induced brain death in the pig. " Transplantation 1994, 58, S414, 0041-1337.

66. Masson F, Thicoipe M, Latapie MJ, Maurette P: "Thyroid function in brain-dead donors. " Transpl.Int. 1990, 3, S226, 0934-0874.

67. Novitzky D, Cooper DK, Reichart B: "Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. " Transplantation 1987, 43, S852, 0041-1337.

68. Gramm HJ, Meinhold H, Bickel U, et al: "Acute endocrine failure after brain death? " Transplantation 1992, 54, S851, 0041-1337.

69. Pratschke J, Wilhelm MJ, Kusaka M, Hancock WW, Tilney NL: "Acute rejection of rat renal allografts is accelerated by donor brain death. " Transplant Proc. 1999, 31, S874, 0041-1345.

70. Pratschke J, Wilhelm MJ, Kusaka M, Hancock WW, Tilney NL: "Activation of proinflammatory genes in somatic organs as a consequence of brain death. " Transplant Proc. 1999, 31, S1003, 0041-1345.

71. Wicomb WN, Novitzky D, Cooper DK, Rose AG: "Forty-eight hours hypothermic perfusion storage of pig and baboon hearts. " J.Surg.Res. 1986, 40, S276, 0022-4804.

72. Wicomb WN, Cooper DK, Lanza RP, Novitzky D, Isaacs S: "The effects of brain death and 24 hours' storage by hypothermic perfusion on donor heart function in the pig. " J.Thorac.Cardiovasc.Surg. 1986, 91, S896, 0022-5223.

73. Cooper DK, Novitzky D, Wicomb WN: "The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. " Ann.R.Coll.Surg.Engl. 1989, 71, S261, 0035-8843.

74. Pratschke J, Wilhelm MJ, Hancock WW, Tullius SG, Neuhaus P, Tilney NL: "Akzelerierte akute Rejektion allogener Nierentransplantate von hirntoten Organspendern. Accelerated rate of acute rejection of renal allografts from brain dead organ-donors. " Langenbecks.Arch.Chir.Suppl. 1999, 1,

75. Land W, Messmer K: "The impact of ischemia/reperfusion injury on specific and non-specific early and late chronic events after organ transplantation. " Transplantation Reviews 1998, 10, S108,

76. Azuma H, Nadeau K, Mackenzie HS, Brenner BM, Tilney NL: "Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. " Transplantation 1997, 63, S519, 0041-1337.

77. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL: "Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. " Transplantation 1997, 64, S190, 0041-1337.


51

78. Azuma H, Nadeau K, Takada M, Tilney NL: "Initial ischemia/reperfusion injury influences late functional and structural changes in the kidney. " Transplant Proc. 1997, 29, S1528, 0041-1345.

79. Tilney NL, Kusaka M, Pratschke J, Wilhelm M: "Chronic rejection. " Transplant Proc. 1998, 30, S1590, 0041-1345.

80. Hariharan S, McBride MA, Bennett LE, Cohen EP: "Risk factors for renal allograft survival from older cadaver donors. " Transplantation 1997, 64, S1748, 0041-1337.

81. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW: "Significance of the donor age effect on kidney transplants. " Clin.Transplant 1997, 11, S366, 0902-0063.

82. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: "High survival rates of kidney transplants from spousal and living unrelated donors. " N.Engl.J.Med. 1995, 333, S333, 0028-4793.

83. Almond PS, Matas A, Gillingham K, et al: "Risk factors for chronic rejection in renal allograft recipients. " Transplantation 1993, 55, S752, 0041-1337.

84. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M: "Cyclosporine-associated chronic nephropathy. " N.Engl.J.Med. 1984, 311, S699, 0028-4793.

85. Mennander A, Tiisala S, Paavonen T, Halttunen J, Hayry P: "Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis. " Transpl.Int. 1991, 4, S173, 0934-0874.

86. Feehally J, Harris KP, Bennett SE, Walls J: "Is chronic renal transplant rejection a non-immunological phenomenon? " Lancet 1986, 2, S486, 0140-6736.

87. Adams DH, Karnovsky MJ: "Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts. " Transplant Proc. 1989, 21, S437, 0041-1345.

88. Grattan MT, Moreno CC, Starnes VA, Oyer PE, Stinson EB, Shumway NE: "Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. " JAMA 1989, 261, S3561, 0098-7484.

89. Loebe M, Schuler S, Zais O, Warnecke H, Fleck E, Hetzer R: "Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. " J.Heart Transplant 1990, 9, S707, 0887-2570.

90. Koskinen PK: "The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts. " Transplantation 1993, 56, S1103, 0041-1337.

91. Beck S, Barrell BG: "Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. " Nature 1988, 331, S269, 0028-0836.

92. Basadonna GP, Matas AJ, Gillingham KJ, et al: "Early versus late acute renal allograft rejection: impact on chronic rejection. " Transplantation 1993, 55, S993, 0041-1337.

93. Gulanikar AC, MacDonald AS, Sungurtekin U, Belitsky P: "The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. " Transplantation 1992, 53, S323, 0041-1337.


52

94. Cook DJ, Terasaki PI: "Renal transplantation on the American continent. " Hrsg.: Brent L, Sells RA, eds : Organ Transplantation Current clinical and immunological concepts London, Balliere Tindall, 1989 S195,

95. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW: "Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. " Hrsg.: .: N.Engl.J.Med. 1992, 327, S834, 0028-4793.

96. Foster MC, Rowe PA, Dennis MJ, Morgan AG, Burden RP, Blamey RW: "Characteristics of cadaveric renal allograft recipients developing chronic rejection. " Ann.R.Coll.Surg.Engl. 1990, 72, S23, 0035-8843.

97. Troppmann C, Gillingham KJ, Benedetti E, et al: "Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. " Hrsg.: .: Transplantation 1995, 59, S962, 0041-1337.

98. Pfaff WW, Howard RJ, Patton PR, Adams VR, Rosen CB, Reed AI: "Delayed graft function after renal transplantation. " Transplantation 1998, 65, S219, 0041-1337.

99. Giral CM, Hourmant M, Cantarovich D, et al: "Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. " Kidney Int. 1998, 54, S972, 0085-2538.

100. Opelz G: "Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. " Transplant Proc. 1997, 29, S73, 0041-1345.

101. Reinke P, Fietze E, Docke WD, Kern F, Ewert R, Volk HD: "Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells. " Transplantation 1994, 58, S35, 0041-1337.

102. Gregory CR, Huang X, Pratt RE, et al: "Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. " Transplantation 1995, 59, S655, 0041-1337.

103. Gregory CR, Huie P, Billingham ME, Morris RE: "Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. " Transplantation 1993, 55, S1409, 0041-1337.

104. Reinke P, Fietze E, Ode HS, et al: "Late-acute renal allograft rejection and symptomless cytomegalovirus infection. " Lancet 1994, 344, S1737, 0140-6736.

105. Azuma H, Chandraker A, Nadeau K, et al: "Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. " Proc.Natl.Acad.Sci.U.S.A. 1996, 93, S12439, 0027-8424.

106. Russell ME, Hancock WW, Akalin E, et al: "Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. " J.Clin.Invest. 1996, 97, S833, 0021-9738.


53

107. Chandraker A, Azuma H, Nadeau K, et al: "Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. " J.Clin.Invest. 1998, 101, S2309, 0021-9738.

108. White E, Hildemann WH, Mullen Y: "Chronic kidney allograft reactions in rats. " Transplantation 1969, 8, S602, 0041-1337.

109. Klempnauer J, Marquarding E: "RT1.C and rat bone marrow transplantation. " Transplant Proc. 1989, 21, S3292, 0041-1345.

110. Lubaroff DM, Rasmussen GT, Hunt HD: "The RT6 T cell antigen: its role in the identification of functional subsets and in T cell activation. " Transplant Proc. 1989, 21, S3251, 0041-1345.

111. Diamond JR, Tilney NL, Frye J, et al: "Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. " Transplantation 1992, 54, S710, 0041-1337.

112. Pleau ME, Hancock WW: "Studies of the human and rat macrophage receptor for interleukin-2 (IL-2R): induction and demonstration that IL-2 boosts interleukin-1 production by IL-2R+ macrophages. " Transplant Proc. 1989, 21, S140, 0041-1345.

113. Kovacs EJ: "Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. " Immunol.Today 1991, 12, S17, 0167-4919.

114. Horii Y, Muraguchi A, Iwano M, et al: "Involvement of IL-6 in mesangial proliferative glomerulonephritis. " J.Immunol. 1989, 143, S3949, 0022-1767.

115. Diamond JR: "Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. " Kidney Int.Suppl. 1991, 31, S29, 0098-6577.

116. Van Goor H, Fidler V, Weening JJ, Grond J: "Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. " Lab.Invest. 1991, 64, S754, 0023-6837.

117. Kashgarian M, Sterzel RB: "The pathobiology of the mesangium. " Kidney Int. 1992, 41, S524, 0085-2538.

118. Teraoka S, Takahashi K, Toma H, et al: "New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation. " Transplant Proc. 1987, 19, S2115, 0041-1345.

119. Ren KY, Brentjens J, Chen YX, Brodkin M, Noble B: "Glomerular macrophage proliferation in experimental immune complex nephritis. " Clin.Immunol.Immuno-pathol. 1991, 60, S384, 0090-1229.

120. Toyabe S, Iwanaga T: "An ultrastructural study of proliferative nephritis induced experimentally by a monoclonal antibody against mesangial cells: replacement of mesangial cells by cells of the monocyte-macrophage system. " Virchows Arch.B.Cell Pathol.Incl.Mol.Pathol. 1992, 61, 0340-6075.

121. Springer TA: "Adhesion receptors of the immune system. " Nature 1990, 346, S425, 0028-0836.


54

122. Isobe M, Yagita H, Okumura K, Ihara A: "Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. " Science 1992, 255, S1125, 0036-8075.

123. Turunen JP, Mattila P, Halttunen J, Häyry P, Renkonen R: "Evidence that lymphocyte traffic into rejecting cardiac allografts is CD11a- and CD49d-dependent. " Transplantation 1992, 54, S1053, 0041-1337.

124. Shimizu Y, Newman W, Gopal TV, et al: "Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. " J.Cell Biol. 1991, 113, S1203, 0021-9525.

125. Graber N, Gopal TV, Wilson D, Beall LD, Polte T, Newman W: "T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. " J.Immunol. 1990, 145, S819, 0022-1767.

126. Matsumoto K, Atkins RC: "Glomerular cells and macrophages in the progression of experimental focal and segmental glomerulosclerosis. " Am.J.Pathol. 1989, 134, S933, 0002-9440.

127. Suranyi MG, Bishop GA, Clayberger C, et al: "Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells. " Kidney Int. 1991, 39, S312, 0085-2538.

128. Brockmeyer C, Ulbrecht M, Schendel DJ, et al: "Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection. " Transplantation 1993, 55, S610, 0041-1337.

129. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM: "Intercellular adhesion molecule 1 on liver allografts during rejection. " Lancet 1989, 2, S1122, 0140-6736.

130. Mues B, Brisse B, Steinhoff G, et al: "Diagnostic assessment of macrophage phenotypes in cardiac transplant biopsies. " Eur.Heart J. 1991, 12, S32, 0195-668X.

131. Pelletier RP, Ohye RG, Vanbuskirk A, et al: "Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo. " J.Immunol. 1992, 149, S2473, 0022-1767.

132. Cosimi AB, Conti D, Delmonico FL, et al: "In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. " J.Immunol. 1990, 144, S4604, 0022-1767.

133. Haug CE, Colvin RB, Delmonico FL, et al: "A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. " Transplantation 1993, 55, S766, 0041-1337.

134. Coffman TM, Sanfilippo FP, Brazy PC, Yarger WE, Klotman PE: "Bilateral native nephrectomy improves renal isograft function in rats. " Kidney Int. 1986, 30, S20, 0085-2538.

135. Murray JE, Balankura O, Greenberg JB, et a: "Reversibility of the kidney homograft reaction by retransplantation and drug therapy. " Ann.Ny.Acad.Sci. 1962, 99, S768,


55

136. Osteen RT, Klebanoff G: "The vascular determinants of reversible rejection. " J.Surg.Res. 1970, 10, S245, 0022-4804.

137. Kupiec WJ, Araujo JL, Towpik E, Araneda D, Tilney NL: "Host-graft relationship: the systemic nature of allograft rejection. " Surgery 1985, 98, S259, 0039-6060.

138. Mennander A, Hayry P: "Reversibility of allograft arteriosclerosis after retransplantation to donor strain. " Transplantation 1996, 62, S526, 0041-1337.

139. Izutani H, Miyagawa S, Shirakura R, et al: "Evidence that graft coronary arteriosclerosis begins in the early phase after transplantation and progresses without chronic immunoreaction. Histopathological analysis using a retransplantation model. " Transplantation 1995, 60, S1073, 0041-1337.

140. Izutani H, Miyagawa S, Mikata S, Shirakura R, Matsuda H: "Essential initial immunostimulation in graft coronary arteriosclerosis induction detected by retransplantation technique in rats: the participation of T cell subsets. " Transpl.Immunol. 1997, 5, S11, 0966-3274.

141. Kootte AM, Paul LC: "Cyclosporine therapy or dietary protein manipulation in chronic renal allograft rejection. " Transplant Proc. 1988, 20, S821, 0041-1345.

142. Perico N, Detcheva A, Khalil EI, Remuzzi G: "Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant. " Kidney Int. 1996, 49, S1283, 0085-2538.

143. Sumrani N, Delaney V, Ding ZK, Butt K, Hong J: "HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function. " Am.J.Kidney Dis. 1990, 16, S417, 0272-6386.

144. Ferns G, Reidy M, Ross R: "Vascular effects of cyclosporine A in vivo and in vitro. " Am.J.Pathol. 1990, 137, S403, 0002-9440.

145. Nadeau KC, Azuma H, Tilney NL: "Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. " Proc.Natl. Acad.Sci.U.S.A. 1995, 92, S8729, 0027-8424.

146. Van Es A, Hermans J, van Bockel JH, Persijn GG, van Hooff JP, de Graeff J: "Effect of warm ischemia time and HLA (A and B) matching on renal cadaveric graft survival and rejection episodes. " Transplantation 1983, 36, S255, 0041-1337.

147. Yilmaz S, Paavonen T, Hayry P: "Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. " Transplantation 1992, 53, S823, 0041-1337.

148. Tullius SG, Reutzel-Selke A, Nieminen-Kelhä M, et al: "The contribution of prolonged ischemia and donor age on chronic renal allograft dysfunction. " J.Am.Soc.Nephrol. 1999, in Press,

149. Kelly KJ, Bonventre JV: "Ischemia/reperfusion injury in transplantation. In " Hrsg.: Tilney NL, Strom TB, Paul LC, eds: Transplantation biology: Cellular and molecular aspects Philadelphia, PA, Lippincott-Raven,, 1996


56

150. Floege J, Eng E, Young BA, Johnson RJ: "Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. " Kidney Int.Suppl. 1993, 39, S47, 0098-6577.

151. Shackleton CR, Ettinger SL, McLoughlin MG, Scudamore CH, Miller, Keown PA: "Effect of recovery from ischemic injury on class I and class II MHC antigen expression. " Transplantation 1990, 49, S641, 0041-1337.

152. Shoskes DA: "Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. " Transplantation 1998, 66, S147, 0041-1337.

153. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV: "Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. " Proc.Natl.Acad. Sci.U.S.A. 1994, 91, S812, 0027-8424.

154. Dragun D, Tullius SG, Park JK, et al: "ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. " Kidney Int. 1998, 54, S590, 0085-2538.

155. Dragun D, Lukitsch I, Tullius SG, et al.: "Inhibition of ICAM-1 by antisense oligonucleotides prevents ischemia/reperfusion injury and enables immediate graft function after renal transplantation. " Kidney Int. 1998, 54, S2113, 0085-2538.

156. Brenner BM, Meyer TW, Hostetter TH: "Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. " N.Engl.J.Med. 1982, 307, S652, 0028-4793.

157. Brenner BM, Milford EL: "Nephron underdosing: a programmed cause of chronic renal allograft failure. " Am.J.Kidney Dis. 1993, 21, S66, 0272-6386.

158. Mackenzie HS, Brenner BM: "Renal mass: A determinant of late allograft outcome. " Hrsg.: Tilney NL, Strom TB, Paul LC, eds: Transplantation biology. Cellular and molecular aspects Philadelphia,PA, Lippincott-Raven, 1996

159. Kiuchi T, Kasahara M, Uryuhara K, et al.: "Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. " Transplantation 1999, 67, S321, 0041-1337.

160. Emond JC, Renz JF, Ferrell LD, et al.: "Functional analysis of grafts from living donors. Implications for the treatment of older recipients. " Ann.Surg. 1996, 224, S544, 0003-4932.

161. Meyer TW, Rennke HG: "Progressive glomerular injury after limited renal infarction in the rat. " Am.J.Physiol. 1988, 254, S856, 0002-9513.

162. Bidani AK, Mitchell KD, Schwartz MM, Navar LG, Lewis EJ: "Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model. " Kidney Int. 1990, 38, S28, 0085-2538.

163. Szabo A, Patschan O, Kuttler B, et a: "Hypertension accelerates the pace of chronic graft dysfunction in the rat. " Transpl.Int. 1998, 11, S10, 0934-0874.

164. Mallick NP, Dyer P, Johnson RW: "Transplantation in the elderly. " Nephrol.Dial.Transplant 1996, 11Suppl9, S95, 0931-0509.


57

165. Azuma H, Heemann UW, Tullius SG, Tilney NL: "Cytokines and adhesion molecules in chronic rejection. " Clin.Transplant. 1994, 8, S168, 0902-0063.

166. Tullius SG, Heidenhain C, Reutzel-Selke A, et al.: "Acceleration of chronic graft rejection by secondary donor-specific skin transplants. " Transplantation (suppl.) 1999, 67, S53,

167. Connolly JK, Dyer PA, Martin S, Parrott NR, Pearson RC, Johnson R: "Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. " Transplantation 1996, 61, S709, 0041-1337.

168. Opelz G, Wujciak T: "Cadaveric kidneys should be allocated according to the HLA match. " Transplant Proc. 1995, 27, S93, 0041-1345.

169. Opelz G: "Impact of HLA compatibility on survival of kidney transplants from unrelated live donors. " Transplantation 1997, 64, S1473, 0041-1337.

170. Fieguth HG, Wahlers T, Schafers HJ, Stangel W, Kemnitz J, Haverich A: "Impact of HLA-compatibility on rejection sequence and survival rate after orthotopic heart transplantation. " Transplant Proc. 1991, 23, S1137, 0041-1345.

171. Valeri M, Adorno D, Piazza A, et al.: "HLA-DR matching and graft survival in heart transplant. " Transplant Proc. 1990, 22, S1906, 0041-1345.

172. Opelz G: "Effect of HLA matching in heart transplantation. Collaborative Heart Transplant Study. " Transplant Proc. 1989, 21, S794, 0041-1345.

173. Frist WH, Oyer PE, Baldwin JC, Stinson EB, Shumway NE: "HLA compatibility and cardiac transplant recipient survival. " Ann.Thorac.Surg. 1987, 44, S242, 0003-4975.

174. Petrossian GA, Nichols AB, Marboe CC, et al.: "Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. " Circulation 1989, 80, SIII122, 0009-7322.

175. Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P: "Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. " Am.J.Pathol. 1991, 138, S791, 0002-9440.

176. Hornick P, Smith J, Pomerance A, et al.: "Influence of acute rejection episodes, HLA matching, and donor/ recipient phenotype on the development of 'early' transplant-associated coronary artery disease. " Circulation 1997, 96, SII, 0009-7322.

177. Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM: "Sex mismatch as a risk factor for chronic rejection of liver allografts. " Lancet 1995, 346, S1117, 0140-6736.

178. Adams D: "Immunological aspects of clinical liver transplantation. " Immunol.Lett. 1991, 29, S69, 0165-2478.

179. Lowes JR, Hubscher SG, Neuberger JM: "Chronic rejection of the liver allograft. " Gastroenterol.Clin.North Am. 1993, 22, S401, 0889-8553.


58

180. Matas AJ, Gillingham KJ, Payne WD, Najarian JS: "The impact of an acute rejection episode on long-term renal allograft survival (t1/2). " Transplantation 1994, 57, S857, 0041-1337.

181. van Saase JL, van der Woude F, Thorogood J, et al.: "The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. " Transplantation 1995, 59, S1280, 0041-1337.

182. Massy ZA, Guijarro C, Kasiske BL: "Clinical predictors of chronic renal allograft rejection. " Kidney Int.Suppl. 1995, 52, S85, 0098-6577.

183. Stovin PG, Sharples LD, Schofield PM, et al.: "Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-relatedcoronary artery disease. " J.Heart Lung Transplant 1993, 12, S110, 1053-2498.

184. Olivari MT, Homans DC, Wilson RF, Kubo SH, Ring WS: "Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. " Circulation 1989, 80, SIII111, 0009-7322.

185. Narrod J, Kormos R, Armitage J, Hardesty R, Ladowski J, Griffith B: "Acute rejection and coronary artery disease in long-term survivors of heart transplantation. " J.Heart Transplant 1989, 8, S418, 0887-2570.

186. Hullett DA, Geraghty JG, Stoltenberg RL, Sollinger HW: "The impact of acute rejection on the development of intimal hyperplasia associated with chronic rejection. " Transplantation 1996, 62, S1842, 0041-1337.

187. Baan CC, Metselaar HJ, Mol WM, et al.: "Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection. " Clin.Transplant 1996, 10, S542, 0902-0063.

188. Platzer C, Ode HS, Reinke P, Docke WD, Ewert R, Volk HD: "Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. " Transplantation 1994, 58, S264, 0041-1337.

189. Reinke P, Schwinzer H, Hoflich C, et al.: "Selective in vivo deletion of alloactivated TH1 cells by OKT3 monoclonal antibody in acute rejection. " Immunol.Lett. 1997, 57, S151, 0165-2478.

190. Dallman MJ: "Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. " Curr.Opin.Immunol 1995, 7, S632, 0952-7915.

191. Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom T: "Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. " J.Immunol. 1995, 154, S5590, 0022-1767.

192. Steiger J, Nickerson PW, Steurer W, Moscovitch LM, Strom T: "IL-2 knockout recipient mice reject islet cell allografts. " J.Immunol. 1995, 155, S489, 0022-1767.


59

193. van Besouw NM, Daane CR, Vaessen LM, Mochtar B, Balk AH, Weimar W: "Donor-specific cytokine production by graft-infiltrating lymphocytes induces and maintains graft vascular disease in human cardiac allografts. " Transplantation 1997, 63, S1313, 0041-1337.

194. Ode HS, Docke WD, Kern F, Emmrich F, Volk HD, Reinke P: "Delayed-type hypersensitivity-like mechanisms dominate late acute rejection episodes in renal allograft recipients. " Transplantation 1996, 61, S1233, 0041-1337.

195. Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM: "Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. " Circulation 1998, 98, SII163, 0009-7322.

196. Blom D, Morrissey N, Mesonero C, et al.: "Tolerance induction by intrathymic inoculation prevents chronic renal allograft rejection. " Transplantation 1998, 65, S272, 0041-1337.

197. Risch K, Heemann U, Graser E, et al.: "Assessment of chronic rejection in permanent accepted renal allografts in anti-CD4 treated rats. " Clin.Nephrol. 1996, 45, S358, 0301-0430.

198. Sablinski T, Sayegh MH, Hancock WW, et al.: "Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. " Transplantation 1991, 51, S226, 0041-1337.

199. Welsh KI, Batchelor JR, Maynard A, Burgos H: "Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. II. Retransplantation of ( AS X AUG)F1 kidneys from AS primary recipients into (AS X WF) F1 secondary hosts. " J.Exp.Med. 1979, 150, S465, 0022-1007.

200. Batchelor JR, Welsh KI, Maynard A, Burgos H: "Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. " J.Exp.Med. 1979, 150, S455, 0022-1007.

201. Batchelor JR, Phillips BE, Grennan D: "Suppressor cells and their role in the survival of immunologically enhanced rat kidney allografts. " Transplantation 1984, 37, S43, 0041-1337.

202. Opelz G, Sengar DP, Mickey MR, Terasaki PI.: "Effect of blood transfusions on subsequent kidney transplants. " Transplant Proc. 1973, 5, S253, 0041-1345.

203. Salvatierra O, Melzer J, Vincenti F, et al.: "Donor-specific blood transfusions versus cyclosporine--the DST story. " Transplant Proc. 1987, 19, S160, 0041-1345.

204. Opelz G, Vanrenterghem Y, Kirste G, et al.: "Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. " Transplantation 1997, 63, S964, 0041-1337.

205. Subbotin V, Sun H, Aitouche A, et al.: "Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. " Transplantation 1997, 64, S690, 0041-1337.


60

206. Akyurek LM, Johnsson C, Lange D, et al.: "Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis. " J.Clin.Invest. 1998, 101, S2889, 0021-9738.

207. Starzl TE, Zinkernagel RM: "Antigen localization and migration in immunity and tolerance. " N.Engl.J.Med. 1998, 339, S1905, 0028-4793.

208. Allison AC, Eugui EM, Sollinger HW: "Mycophenolate mofetil (RS61443): mechanisms of action and effects in transplantation " Transplant.Rev. 1993, 7, S129,

209. Allison AC, Almquist SJ, Muller CD, Eugui EM: "In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. " Transplant Proc. 1991, 23, S10, 0041-1345.

210. Platz KP, Sollinger HW, Hullett DA, Eckhoff DE, Eugui EM, Allison AC: "RS-61443-a new, potent immunosuppressive agent. " Transplantation 1991, 51, S27, 0041-1337.

211. Sollinger HW, Deierhoi MH, Belzer FO, Diethelm AG, Kauffman RS: "RS-61443--a phase I clinical trial and pilot rescue study. " Transplantation 1992, 53, S428, 0041-1337.

212. European Mycophenolate Mofetil Cooperative Study Group: "Mycophenolate mofetil in renal transplantation 3-year results from the placebo-controlled trial. " Transplantation 1999, 68, S391, 0041-1337.

213. European Mycophenolate Mofetil Cooperative Study Group: "Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. " Hrsg.: .: Lancet 1995, 345, S1321, 0140-6736.

214. Sollinger HW: "Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. " Transplantation 1995, 60, S225, 0041-1337.

215. Bonventre JV, Colvin RB: "Adhesion molecules in renal disease. " Curr.Opin.Nephrol.Hypertens. 1996, 5, S254, 1062-4821.

216. Bevilacqua MP, Nelson RM, Mannori G, Cecconi O: "Endothelial-leukocyte adhesion molecules in human disease. " Annu.Rev.Med. 1994, 45, S361, 0066-4219.

217. Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H: "Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. " J.Leukoc.Biol. 1995, 57, S368, 0741-5400.

218. Ioculano M, Squadrito F, Altavilla D, et al.: "Antibodies against intercellular adhesion molecule 1 protect against myocardial ischaemia-reperfusion injury in rat. " Eur.J.Pharmacol. 1994, 264, S143, 0014-2999.

219. Mason DW, Morris PJ: "Effector mechanisms in allograft rejection. " Annu.Rev.Immunol. 1986, 4, S119, 0732-0582.

220. Tilney NL, Kupiec WJ, Heidecke CD, Lear PA, Strom TB: "Mechanisms of rejection and prolongation of vascularized organ allografts. " Immunol.Rev. 1984, 77, S185, 0105-2896.


61

221. Hayry P, von WE, Parthenais E, et al.: "The inflammatory mechanisms of allograft rejection. " Immunol.Rev. 1984, 77, S85, 0105-2896.

222. Gowans JL, McGregor DD, Collen DM, et a: "Initiation of immune response by small lymphocytes. " Nature 1962, 196, S651, 0028-0836.

223. Dallman MJ: "Cytokines as mediators of organ graft rejection and tolerance. " Curr.Opin.Immunol. 1993, 5, S788, 0952-7915.

224. Hutchinson IV: "Suppressor T cells in allogeneic models. " Transplantation 1986, 41, S547, 0041-1337.

225. Tilney NL, Kupiec WJ: "The biology of acute transplant rejection. " Ann.Surg. 1991, 214, S98, 0003-4932.

226. Tilney NL, Kupiec WJ: "Acute rejection. In " Hrsg.: Tilney NL, Strom TB, Paul.L.C., eds: Transplantation Biology Philadelphia, PA, Lippincott-Raven, 1996

227. Medawar PB: "Immunity to homologous grafted skin. II. The relationsship between the antigens of blood and skin. " Br.J.Exp.Path. 1946, 27, S15,

228. Simenson M, Buemann J, Grammeltof A, et a: "Biological incompatibility in kidney transplantation in dogs. I. Experimental and morphological investigations. " Acta Pathol.Microbiol.Scand. 1953,

229. Chapman JR, Taylor C, Ting A, Morris PJ: "Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. " Transplantation 1986, 42, S91, 0041-1337.

230. Jordan SC, Yap HK, Sakai RS, Alfonso P, Fitchman M: "Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch. " Transplantation 1988, 46, S585, 0041-1337.

231. Schuurman HJ, Jambroes G, Borleffs JC, Slootweg PJ, Meyling FH, de GG: "Acute humoral rejection after heart transplantation. " Transplantation 1988, 46, S603, 0041-1337.

232. Sanfilippo FP, Vaughn WK, Peters TG, et al.: "Factors affecting the waiting time of cadaveric kidney transplant candidates in the United States. " JAMA 1992, 267, S247, 0098-7484.

233. Koka P, Cecka JM: "Sensitization and crossmatching in renal transplantation. " Clin.Transpl. 1989, S379, 0890-9016.

234. Scornik JC, Salomon DR, Howard RJ, Pfaff WW: "Evaluation of antibody synthesis in broadly sensitized patients. " Transplantation 1988, 45, S95, 0041-1337.

235. Opelz G: "For the collaborative transplantation study. To transfuse or not before transplantation. In " Hrsg.: Morris PJ, Tilney NL, eds: Transplantation Reviews, Volume 2 Philadelphia, PA, Pa Saunders, 1988 S77,

236. Opelz G: "Influence of HLA matching on survival of second kidney transplants in cyclosporine-treated recipients. " Transplantation 1989, 47, S823, 0041-1337.

237. Lavee J, Kormos RL, Duquesnoy RJ, et al.: "Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. " J.Heart Lung Transplant 1991, 10, S921, 1053-2498.


62

238. Brasile L, Zerbe T, Rabin B, Clarke J, Abrams A, Cerilli J: "Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. " Transplantation 1985, 40, S672, 0041-1337.

239. Cerilli J, Brasile L, Galouzis T, Lempert N, Clarke J: "The vascular endothelial cell antigen system. " Transplantation 1985, 39, S286, 0041-1337.

240. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH: "Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. " Transplantation 1991, 52, S214, 0041-1337.

241. Platt JL, Bach FH: "The barrier to xenotransplantation. " Transplantation 1991, 52, S937, 0041-1337.

242. Galili U, Rachmilewitz EA, Peleg A, Flechner I: "A unique natural human IgG antibody with anti-alpha-galactosyl specificity. " J.Exp.Med. 1984, 160, S1519, 0022-1007.

243. Calne RY: "Organ transplantation between widely disparate species. " Transplant Proc. 1970, 2, S550, 0041-1345.

244. Aksentijevich I, Sachs DH, Sykes M: "Natural antibodies can inhibit bone marrow engraftment in the rat-mouse species combination. " J.Immunol. 1991, 147, S4140, 0022-1767.


[Titelseite] [1] [2] [3] [4] [5] [Abkürzungsverzeichnis] [Bibliographie] [Anhang] [Danksagung] [Lebenslauf]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Mon Nov 13 10:52:06 2000